primary

PR Emerges as the Primary Source for Journalists in High-Pressure Newsrooms

Cision's 2026 State of the Media Report reveals 66% of journalists rely on PR for story ideasCHICAGO, May 13, 2026…

6 days ago

WhiteSwell Announces Primary Clinical Trial Results Simultaneously at Heart Failure 2026 Congress and in European Journal of Heart Failure related to the DELTA-HF Study in Acute Decompensated Heart Failure

GALWAY, Ireland, May 10, 2026 (GLOBE NEWSWIRE) -- WhiteSwell, a clinical-stage medtech company pioneering a new treatment paradigm for acute…

1 week ago

Celcuity’s Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort

MINNEAPOLIS, May 01, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies…

2 weeks ago

Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting

Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability scores, and eliminated the need for chronic immunotherapies…

4 weeks ago

SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD

TAMPA, Fla., March 31, 2026 /PRNewswire/ -- Concept Medical Inc. (CMI), a global leader in innovative drug-delivery technology across vascular…

2 months ago

Silver Lake and Nomura Securities Form a Strategic Partnership to Establish a Primary Trading Account and Co-Create a New Blueprint for Japans Capital Markets

Menlo Park, California, March 06, 2026 (GLOBE NEWSWIRE) -- We are pleased to announce that Silver Lake Partners, a global…

2 months ago

Star Health Launches 32 Arogya Seva Kendras; to Provide Primary Healthcare Access to over a Million Lives

First Arogya Seva Kendra inaugurated in Egmore, Chennai; Tamil Nadu rollout includes Nagercoil, Thoothukudi, Tiruppur and KarurStructured clinics to offer doctor…

3 months ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the…

3 months ago

InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial

BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the…

5 months ago

Symbotic Announces Pricing of Primary and Secondary Offering of Class A Common Stock

December 04, 2025 22:05 ET  | Source: Symbotic Inc. WILMINGTON, Mass., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq:…

6 months ago
Show more Posts